Current Region: Europe
Your selections will be saved and used to recommend products based on your interests.
Jun 4 2013 9:00AM - Jun 5 2013 4:00PM | NH Harrington Hall
5-25 Harrington Gardens
This two day conference will focus on the impact of the new Pharmacovigilance legislation on regulatory affairs, from various perspectives. The changes in legislation will affect the way product assessment is carried out in both pre- and post-authorisation phases, introduce new obligations to Marketing Authorisation Holders, and bring in continuous benefit risk assessment. This important conference will also be looking at the impact of the new Pharmacovigilance Risk Assessment Committee (PRAC) on the life-cycle management of products and the PRAC’s interactions with other Committees.
This conference is aimed at intermediate and experienced professionals from
Group Discounts Available – Send 3 participants and the 4th is free!
Conditions apply. Online registration not available for this offer. Call DIA in Europe on +41 61 225 51 51 or email for further information.
DIA has blocked a limited number of rooms at the following hotel:
NH Harrington Hall Hotel5-25 Harrington Gardens South Kensington, London SW7 4JW UK
Tel.: +44 207 396 96 96Fax: +44 207 398 46 61Email: email@example.com
At the special rate of GBP 180.00 per room/night inclusive of breakfast and VAT.
In order to make a reservation, please contact the hotel directly: firstname.lastname@example.org or by phone: +44 870 735 0358.
Please quote the booking reference (group name and code)
Group name: DIA
Group code: 19429982
The special room rate will be available until 4 May 2013 or until the group block is sold-out, whichever comes first.
Cancellation policy: In case of no-show or late cancellation the costs will be charged onto your credit card. Once your booking is confirmed, the individual cancellation policy will be 7 days prior to arrival.
KUECHENGASSE 16, POSTFACH
TEL.: +41 61 225 51 51
FAX: +41 61 225 51 52
Senior Expert; Chair, Coordination Group for Mutual Recognition and DecentraliseFederal Institute for Drugs and Medical Devices, Germany
Senior Director, Regulatory Policy & IntelligenceAbbvie, United Kingdom
Head of Regulatory AffairsEuropean Medicine Agency, United Kingdom
Vice PresidentBristol-Myers Squibb Company , France
CANCELLATION POLICY: All cancellations must be made in writing and be received at the DIA office five working days prior to the event start date. Full event cancellations are subject to an administrative fee:
If you do not cancel five working days prior to the event start date and do not attend, you will be responsible for the full registration fee. DIA reserves the right to alter the venue and dates if necessary. If an event is cancelled DIA is not responsible for airfare, hotel or other costs incurred by registered attendees. Registered attendees are responsible for cancelling their own hotel and travel reservations.